RXI Pharma (RXII) Tops Q2 EPS by 2c

August 11, 2016 7:04 AM EDT
Get Alerts RXII Hot Sheet
Trade RXII Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

RXI Pharma (NASDAQ: RXII) reported Q2 EPS of ($0.34), $0.02 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $9 thousand, versus $0 reported last year.

For earnings history and earnings-related data on RXI Pharma (RXII) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment